Stasiak, P.; Sopel, J.; Lipowicz, J.M.; Rawłuszko-Wieczorek, A.A.; Korbecki, J.; Januchowski, R.
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models. Int. J. Mol. Sci. 2025, 26, 1124.
https://doi.org/10.3390/ijms26031124
AMA Style
Stasiak P, Sopel J, Lipowicz JM, Rawłuszko-Wieczorek AA, Korbecki J, Januchowski R.
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models. International Journal of Molecular Sciences. 2025; 26(3):1124.
https://doi.org/10.3390/ijms26031124
Chicago/Turabian Style
Stasiak, Piotr, Justyna Sopel, Julia Maria Lipowicz, Agnieszka Anna Rawłuszko-Wieczorek, Jan Korbecki, and Radosław Januchowski.
2025. "The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models" International Journal of Molecular Sciences 26, no. 3: 1124.
https://doi.org/10.3390/ijms26031124
APA Style
Stasiak, P., Sopel, J., Lipowicz, J. M., Rawłuszko-Wieczorek, A. A., Korbecki, J., & Januchowski, R.
(2025). The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models. International Journal of Molecular Sciences, 26(3), 1124.
https://doi.org/10.3390/ijms26031124
